1. Home
  2. OCSL vs PLSE Comparison

OCSL vs PLSE Comparison

Compare OCSL & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCSL
  • PLSE
  • Stock Information
  • Founded
  • OCSL 2007
  • PLSE 2014
  • Country
  • OCSL United States
  • PLSE United States
  • Employees
  • OCSL N/A
  • PLSE N/A
  • Industry
  • OCSL Finance: Consumer Services
  • PLSE Medical/Dental Instruments
  • Sector
  • OCSL Finance
  • PLSE Health Care
  • Exchange
  • OCSL Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • OCSL 1.3B
  • PLSE 1.1B
  • IPO Year
  • OCSL 2008
  • PLSE 2016
  • Fundamental
  • Price
  • OCSL $15.72
  • PLSE $19.58
  • Analyst Decision
  • OCSL Hold
  • PLSE
  • Analyst Count
  • OCSL 9
  • PLSE 0
  • Target Price
  • OCSL $17.29
  • PLSE N/A
  • AVG Volume (30 Days)
  • OCSL 867.4K
  • PLSE 137.8K
  • Earning Date
  • OCSL 02-04-2025
  • PLSE 10-30-2024
  • Dividend Yield
  • OCSL 13.99%
  • PLSE N/A
  • EPS Growth
  • OCSL N/A
  • PLSE N/A
  • EPS
  • OCSL 0.72
  • PLSE N/A
  • Revenue
  • OCSL $381,665,000.00
  • PLSE N/A
  • Revenue This Year
  • OCSL N/A
  • PLSE N/A
  • Revenue Next Year
  • OCSL N/A
  • PLSE N/A
  • P/E Ratio
  • OCSL $21.84
  • PLSE N/A
  • Revenue Growth
  • OCSL 0.63
  • PLSE N/A
  • 52 Week Low
  • OCSL $14.89
  • PLSE $6.60
  • 52 Week High
  • OCSL $21.64
  • PLSE $22.69
  • Technical
  • Relative Strength Index (RSI)
  • OCSL 58.39
  • PLSE 58.17
  • Support Level
  • OCSL $14.89
  • PLSE $17.18
  • Resistance Level
  • OCSL $15.43
  • PLSE $18.72
  • Average True Range (ATR)
  • OCSL 0.17
  • PLSE 1.10
  • MACD
  • OCSL 0.10
  • PLSE 0.03
  • Stochastic Oscillator
  • OCSL 86.46
  • PLSE 79.66

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: